Technical Analysis for OPTN - OptiNose, Inc.

Grade Last Price % Change Price Change
grade F 8.0 -2.08% -0.17
OPTN closed down 2.08 percent on Friday, May 24, 2019, on 2.01 times normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical OPTN trend table...

Date Alert Name Type % Chg
Lower Bollinger Band Walk Weakness 0.00%
Wide Bands Range Expansion 0.00%
Below Lower BB Weakness 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Down 5 Days in a Row Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Expansion Breakdown Bearish Swing Setup -2.08%
Reversal New Lows Setup Bearish Swing Setup -2.08%

Older signals for OPTN ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
OptiNose, Inc. is a pharmaceutical company. The Company is focused on the development and commercialization of products for patients treated by ear, nose and throat, or ENT, and allergy specialists. The Company’s products candidates include XHANCE (Nasal Polyps), XHANCE (Chornic Sinusitis) OPN-300, OPN-021, and other. The Company’s lead product, XHANCE (fluticasone propionate) nasal spray, utilizes breath powered exhalation delivery system (EDS), to deliver a topically acting and potent anti-inflammatory corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps. XHANCE has a differentiated clinical profile with the potential to become part of the standard of care for this disease because it is able to deliver medication to the primary site of inflammation
Medicine Pharmaceutical Clinical Medicine Organ Systems Disease Inflammation Respiratory Therapy Allergy Glucocorticoids Sinusitis
Is OPTN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 30.0
52 Week Low 5.66
Average Volume 148,807
200-Day Moving Average 10.0146
50-Day Moving Average 9.7358
20-Day Moving Average 9.5465
10-Day Moving Average 8.978
Average True Range 0.6501
ADX 19.85
+DI 11.9192
-DI 26.7081
Chandelier Exit (Long, 3 ATRs ) 9.0897
Chandelier Exit (Short, 3 ATRs ) 9.8303
Upper Bollinger Band 11.1004
Lower Bollinger Band 7.9926
Percent B (%b) 0.0
BandWidth 32.554339
MACD Line -0.3848
MACD Signal Line -0.1743
MACD Histogram -0.2105
Fundamentals Value
Market Cap 302.09 Million
Num Shares 37.8 Million
EPS -19.61
Price-to-Earnings (P/E) Ratio -0.41
Price-to-Sales 0.00
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 9.01
Resistance 3 (R3) 9.08 8.81 8.84
Resistance 2 (R2) 8.81 8.56 8.78 8.78
Resistance 1 (R1) 8.41 8.40 8.28 8.34 8.73
Pivot Point 8.14 8.14 8.08 8.11 8.14
Support 1 (S1) 7.74 7.89 7.61 7.67 7.27
Support 2 (S2) 7.47 7.73 7.44 7.22
Support 3 (S3) 7.07 7.47 7.16
Support 4 (S4) 7.00